Fred Middleton Insider Profile

18 Followers
Fred Middleton, Director at Endocyte, holds 3.62M shares in Chimerix (Ticker: CMRX), holds 2.32M shares in CalciMedica (Ticker: CALC), holds 0.00 shares in Endocyte (Ticker: ECYT).
tipranks
Fred Middleton

Fred Middleton
Endocyte (ECYT)
Director

Ranked #1,084 out of 99,172 Corporate Insiders

Profitable Transactions

50%
11 out of 22 Profitable Transactions

Average Return

+41.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$16M
52.21%
21.30%
19.39%
7.10%
A breakdown of Fred Middleton's holdings

Insider Roles

CalciMedica
(CALC)
Director, Ten Percent Owner
Chimerix
(CMRX)
Director
Stereotaxis
(STXS)
Director
Pacira Pharmaceuticals
(PCRX)
Director
Roles that Fred Middleton holds in companies

Most Profitable Insider Trade

Stock:
Chimerix
(CMRX)
Rating:Informative Buy
Date:Mar 16, 2020 - Mar 16, 2021
Return:+628.30%
The most profitable trade made by Fred Middleton

Fred Middleton's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ECYT
Endocyte
Dec 21, 2018
Uninformative Sell
99.74M
$0.00
Chimerix
Oct 30, 2024
Director
Uninformative Sell
$3.51M
CalciMedica
Jan 25, 2024
Director, Ten Percent Owner
Informative Buy
2.51M
$8.60M
Stereotaxis
Mar 05, 2018
Director
Informative Buy
43.08K
$3.19M
Pacira Pharmaceuticals
Jun 25, 2013
Director
Uninformative Sell
2.21M
$1.17M
List of latest transactions for each holding click on a transaction to see Fred Middleton's performance on stock

Fred Middleton insider profile FAQ

What is the percentage of profitable transactions made by Fred Middleton?
The percentage of profitable transactions made by Fred Middleton is 50%.
    What is the average return per transaction made by Fred Middleton?
    The average return per transaction made by Fred Middleton is 41.40%.
      What stocks does Fred Middleton hold?
      Fred Middleton holds: ECYT, CMRX, CALC, STXS, PCRX stocks.
        What was Fred Middleton’s latest transaction?
        Fred Middleton latest transaction was an Uninformative Sell of ―.
          What was Fred Middleton's most profitable transaction?
          Fred Middleton’s most profitable transaction was an Informative Buy of CMRX stock on March 16, 2020. The return on the trade was 628.30%.
            What is Fred Middleton's role in Endocyte?
            Fred Middleton's role in Endocyte is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.